Jennifer M Snaman1,2, Gabrielle Helton3, Rachel L Holder4, Eve Wittenberg5, Anna Revette6, James A Tulsky3,7, Justin N Baker8, Joanne Wolfe3,9. 1. Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA, 02215, USA. Jennifer_Snaman@dfci.harvard.edu. 2. Department of Pediatrics, Boston Children's Hospital, Boston, MA, USA. Jennifer_Snaman@dfci.harvard.edu. 3. Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA, 02215, USA. 4. Department of Psychology, Virginia Commonwealth University, Richmond, VA, USA. 5. Center for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, MA, USA. 6. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. 7. Division of Palliative Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA. 8. Division of Quality of Life and Palliative Care, Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA. 9. Department of Pediatrics, Boston Children's Hospital, Boston, MA, USA.
Abstract
PURPOSE: Adolescents and young adults (AYAs) with cancer report feeling ill-informed about their cancer treatment options. Tools are needed to inform AYAs about treatment choices and amplify the AYA's voice in medical decision-making. We developed MyPref, a conjoint-analysis based tool that quantifies AYA preferences for future cancer treatments. METHODS: We conducted a staged pilot study of MyPref utilizing an intervention mixed methods design. AYAs and their parent or trusted person (PTP) completed MyPref and received a summary report of their preferences for treatment-related factors. Participants later completed the Preparation for Decision Making Scale and MyPref Experience Questionnaire and engaged in semi-structured interviews. Oncologists reported on the perceived accuracy and utility of MyPref. We used a weaving technique for presenting mixed methods data. RESULTS: Fifteen AYAs with advanced cancer, 7 PTPs, and 12 providers participated in this pilot; 32 (94%) completed all study items. AYA/PTPs stated study participation was useful and believed MyPref allowed for improved understanding of treatment factors and consideration, organization, and visualization of preferences. All providers agreed that MyPref made them think about patient's preferences and 9 (75%) reported they planned to change their approach to discussions about preferences for future treatments. CONCLUSION: MyPref is an objective way to estimate AYA and PTP preferences for future treatment characteristics. This novel tool may be a useful way to engage AYAs and PTPs in discussions around preferences for treatment and prepare AYAs for future decision-making. We are currently evaluating this tool longitudinally to determine the impact on actual treatment decisions.
PURPOSE: Adolescents and young adults (AYAs) with cancer report feeling ill-informed about their cancer treatment options. Tools are needed to inform AYAs about treatment choices and amplify the AYA's voice in medical decision-making. We developed MyPref, a conjoint-analysis based tool that quantifies AYA preferences for future cancer treatments. METHODS: We conducted a staged pilot study of MyPref utilizing an intervention mixed methods design. AYAs and their parent or trusted person (PTP) completed MyPref and received a summary report of their preferences for treatment-related factors. Participants later completed the Preparation for Decision Making Scale and MyPref Experience Questionnaire and engaged in semi-structured interviews. Oncologists reported on the perceived accuracy and utility of MyPref. We used a weaving technique for presenting mixed methods data. RESULTS: Fifteen AYAs with advanced cancer, 7 PTPs, and 12 providers participated in this pilot; 32 (94%) completed all study items. AYA/PTPs stated study participation was useful and believed MyPref allowed for improved understanding of treatment factors and consideration, organization, and visualization of preferences. All providers agreed that MyPref made them think about patient's preferences and 9 (75%) reported they planned to change their approach to discussions about preferences for future treatments. CONCLUSION: MyPref is an objective way to estimate AYA and PTP preferences for future treatment characteristics. This novel tool may be a useful way to engage AYAs and PTPs in discussions around preferences for treatment and prepare AYAs for future decision-making. We are currently evaluating this tool longitudinally to determine the impact on actual treatment decisions.
Entities:
Keywords:
Adolescents and young adults; Advanced cancer; Communication; Decision-making; Pediatric oncology
Authors: Carol Bennett; Ian D Graham; Elizabeth Kristjansson; Stephen A Kearing; Kate F Clay; Annette M O'Connor Journal: Patient Educ Couns Date: 2009-06-26
Authors: Glyn Elwyn; Annette O'Connor; Dawn Stacey; Robert Volk; Adrian Edwards; Angela Coulter; Richard Thomson; Alexandra Barratt; Michael Barry; Steven Bernstein; Phyllis Butow; Aileen Clarke; Vikki Entwistle; Deb Feldman-Stewart; Margaret Holmes-Rovner; Hilary Llewellyn-Thomas; Nora Moumjid; Al Mulley; Cornelia Ruland; Karen Sepucha; Alan Sykes; Tim Whelan Journal: BMJ Date: 2006-08-14
Authors: Jennifer M Snaman; Lindsay Blazin; Rachel L Holder; Joanne Wolfe; Justin N Baker Journal: J Adolesc Young Adult Oncol Date: 2018-10-25 Impact factor: 2.223
Authors: Joan E Haase; Kristin Stegenga; Sheri L Robb; Mary C Hooke; Debra S Burns; Patrick O Monahan; Timothy E Stump; Amanda K Henley; Paul R Haut; Brooke Cherven; Lona Roll; Anne-Marie Langevin; Rita H Pickler; Karen Albritton; DeAnna Hawkins; Erin Osterkamp; Pauline Mitby; Jackie Smith; Virginia R Diaz; Erica Garcia-Frausto; Margo Moore Journal: Cancer Nurs Date: 2021-11-24 Impact factor: 2.760